The role of desmin alterations in mechanical electrical feedback in heart failure

Lin Chen1, Li Wang1, Xingyi Li1

  • 1The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

Life Sciences
|December 4, 2019
PubMed
Abstract

Insights

Desmin alterations contribute to heart failure arrhythmias by disrupting mechanoelectric feedback via the NF-κB pathway. Inhibiting this pathway may offer a therapeutic target for ventricular arrhythmias.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Cellular Mechanotransduction

Background:

  • Mechanoelectric feedback (MEF) plays a critical role in cardiac electrical stability, with its dysfunction implicated in malignant arrhythmias observed in heart failure (HF).
  • Desmin, a key cytoskeletal protein, is hypothesized to act as a mechanoelectrical transducer, potentially mediating MEF alterations in the context of HF.

Purpose of the Study:

  • To investigate the role of desmin alterations in mechanoelectric feedback within a heart failure model.
  • To elucidate the underlying molecular mechanisms by which desmin influences cardiac electrical activity and calcium handling in HF.

Main Methods:

  • Employed both in vivo rat models (sham, HF, streptomycin, MDL-28170) and an in vitro cardiomyocyte model (NC, si-desmin, si-desmin + NBD IKK).
  • Assessed ventricular arrhythmias (VA), desmin expression, NF-κB pathway activation (IKKβ, p-IKKβ, IKBα, p-NF-κB), SERCA2 levels, and intracellular calcium (Ca2+) handling.

Main Results:

  • Heart failure significantly increased ventricular arrhythmias; desmin breakdown correlated with VA occurrence.
  • Desmin knockdown in cardiomyocytes activated the NF-κB pathway, reduced SERCA2 expression, and caused abnormal Ca2+ distribution.
  • NF-κB inhibition restored SERCA2 levels and alleviated Ca2+ handling abnormalities.

Conclusions:

  • Desmin appears to modulate mechanoelectric feedback in heart failure, potentially through activation of the NF-κB signaling pathway.
  • These findings highlight desmin and the NF-κB pathway as potential therapeutic targets for managing ventricular arrhythmias in heart failure patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
624
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
405
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
179
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
852